Annual Drug Patent Expirations for KYNAMRO
Kynamro is a drug marketed by Kastle Theraps Llc and is included in one NDA. There are four patents protecting this drug.
This drug has five hundred and twenty-eight patent family members in nineteen countries.
The generic ingredient in KYNAMRO is mipomersen sodium. Additional details are available on the mipomersen sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
